Search Results - Fengming Tang
- Showing 1 - 9 results of 9
-
1
Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study by Jesús Medina, Kamlesh Khunti, Stéphane Pintat, Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Eric Wittbrodt, Filip Surmont
Published in BMJ Open Diabetes Research & Care (2019-05-01)Get full text
Article -
2
Long‐Term Outcomes Among Elderly Survivors of Out‐of‐Hospital Cardiac Arrest by Paul S. Chan, Bryan McNally, Brahmajee K. Nallamothu, Fengming Tang, Bradley G. Hammill, John A. Spertus, Lesley H. Curtis
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2016-03-01)Get full text
Article -
3
The Impact of De‐escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention by Mohammed Qintar, Arooge Towheed, Fengming Tang, Adam C. Salisbury, P. Michael Ho, J. Aaron Grantham, John A. Spertus, Suzanne V. Arnold
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2017-10-01)Get full text
Article -
4
Discharge Heart Rate After Hospitalization for Myocardial Infarction and Long‐Term Mortality in 2 US Registries by Venkatesh Alapati, Fengming Tang, Esti Charlap, Paul S. Chan, Paul A. Heidenreich, Philip G. Jones, John A. Spertus, Vankeepuram Srinivas, Jorge R. Kizer
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2019-02-01)Get full text
Article -
5
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER by Suzanne V. Arnold, Fengming Tang, Andrew Cooper, Hungta Chen, Marilia B. Gomes, Wolfgang Rathmann, Iichiro Shimomura, Jiten Vora, Hirotaka Watada, Kamlesh Khunti, Mikhail Kosiborod
Published in BMC Endocrine Disorders (2022-04-01)Get full text
Article -
6
Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme by Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Iichiro Shimomura, Marilia B Gomes, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Hungta Chen, Javier Cid-Ruzafa
Published in BMJ Open (2020-08-01)Get full text
Article -
7
Impact of micro‐ and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study by Suzanne V. Arnold, Kamlesh Khunti, Fengming Tang, Hungta Chen, Antonio Nicolucci, Marilia B. Gomes, Linong Ji, Marina V. Shestakova, Hirotaka Watada, Andrew Cooper, Peter Fenici, Niklas Hammar, Jesús Medina, Mikhail Kosiborod, the DISCOVER investigators
Published in Endocrinology, Diabetes & Metabolism (2022-03-01)Get full text
Article -
8
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study by Jesús Medina, Peter Fenici, Linong Ji, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, Wolfgang Rathmann, Suzanne V Arnold, Iichiro Shimomura, Mikhail Kosiborod, Hungta Chen, Andrew Cooper, Brenda Bongaerts, Bernard H Charbonnel, Marilia Gomes, Marina Shestakova
Published in BMJ Open Diabetes Research & Care (2021-03-01)Get full text
Article -
9
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program) by Mikhail Kosiborod, Marilia B. Gomes, Antonio Nicolucci, Stuart Pocock, Wolfgang Rathmann, Marina V. Shestakova, Hirotaka Watada, Iichiro Shimomura, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Kamlesh Khunti, for The DISCOVER investigators
Published in Cardiovascular Diabetology (2018-11-01)Get full text
Article
